Pfizer: Risks Priced In, Buy The Exceptional Valuation And Yield

Pfizer Inc (NYSE: PFE ) has had a troublesome few years after the revenue boom generated by its COVID vaccine. The company was among the few beneficiaries of the need to rapidly vaccinate massive swaths of the global population, competing chieflyRetail investor researching mostly semiconductors and fintech. Some general macro musings. My goal is to bring you timely and digestible research on the stocks that I cover.Analyst’s Disclosure: I/we have a beneficial long position in the shares of PFE either throug ...